- Email: [email protected]
Minutes: General Assembly International Association for the Study of Lung Cancer
Lung Cancer, 8 (1992) 113-I I8 0 1992 Elsevier Science Publishers B.V. All rights reserved 0169-5002/92/$05.00
113
LUNG 00110
Minutes: General Assembly International
Association
for the Study of Lung Cancer
Melbourne, November 14th, 1991 Agenda: 1. 2. 3. 4. 5.
Report from the President Report from the Treasurer Report from the Auditing Committee Election of new Officers and Board Members Miscellaneous
Ad 1: Report from the President Heine H. Hansen summarized the development of the various activities of the organization since the 5th World Conference on Lung Cancer in Interlaken, Switzerland, covering the following items: Membership
A further increase in membership was noted bringing the total number of members to 951 - see Fig. 1 and Table 1. The Middle East, Eastern Europe, Africa and South America are still poorly represented. A supplement to the membership roster will be distributed in 1992. World Conferences
6th World Conference, Melbourne, was very well attended, with roughly 1200 registrants, of whom more than 600 were non-members. A detailed report from the Secretary General, Dr. David Ball, will later be published in Lung Cancer. 7th World Conference is scheduled to take place in Colorado Springs, 1994, June 26July with Paul A. Bunn as the organizer.
1
8th World Conference is scheduled to take place in Europe 1997 and an announcement concerning the conditions will be placed in Lung Cancer with the deadline for applications to be submitted before September 1, 1993. 9th World Conference, year 2000 will take place in the Far East. An announcement will appear in Lung Cancer in 1993 with the decision to be taken no later than January 1, 1994.
114
I.A.S.L.C. Members 1974 - 1991
600
1991
1988 Fig. I.
TABLE 1 Members of the I.A.S.L.C. by country Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Colombia Czechoslovakia Denmark Egypt Finland France
I
24 I 11 6 1 32 1 24 2 2 24 2 2 21
Germany Greece Hong Kong Hungary India Indonesia Iran Ireland Israel Italy Japan Korea Latvia Lithuania Mexico
13 I 4 3 4
I 1 1 2 41 260 1
1 1 2
The Netherlands New Zealand Norway Panama Poland Portugal S. Africa Spain Sweden Switzerland Taiwan U.K. U.S.A. Venezuela Yugoslavia New Members 1991 Retired Members 1990-1991 Total
15
1 5
I 6 9 5 6 12 10 11 II 245 1 3 56 22 900
115 Workshops
During the last 3 years the following workshops have taken place: “Workshop on Combined Radiotherapy Modalities in Lung Cancer”, Le Havre, France,
June 1987. “Third Workshop on Small Cell Lung Cancer”, Elsinore, Denmark, June 1989. “Second Workshop on Therapy of Non-Small Cell Lung Cancer “, Bruges, Belgium, June
1990. “Third Lung Tumour Biology Workshop”, Cambridge, England, August 1990.
The following proceedings have been published in Lung Cancer 198881991: International Conference on Hormones, Growth Factors and Oncogenes in Pulmonary Carcinoma. Edited by: George D. Sorenson, 1988;4: 117-220. Fifth World Conference on Lung Cancer, Interlaken, Switzerland. Edited by: Rudolf A. Joss and Kurt W. Brunner, 1988;4:Suppl. Workshop on Combined Radiotherapy Modalities in Lung Cancer, Le Havre, France. Summary by: R. Arriagada and T. Le Chevalier, 1989;5:15-18. The Guangzhou First Symposium on Lung Cancer. Summary by: Du Yingxiu, 1989;5:37-40. Third Workshop on Small Cell Lung Cancer, Elsinore, Denmark. Edited by: Heine H. Hansen and Paul E.G. Kristjansen, 1989;5: 119-326. An International Conference on Lung Cancer, Boston, Massachusetts. Boston University Medical Center in cooperation with I.A.S.L.C. Summary by: S.D. Bernal and P.J. Hesketh, 1990;5-6:192-208. Second Workshop on Therapy of Non-Small Cell Lung Cancer, Bruges, Belgium. Edited by: P. van Houtte, 1991;7:1-132. Third Lung Tumour Biology Workshop, Cambridge, England. Report by: N.M. Bleehen, PH. Rabbits and J.G. Reeve, 1991;7:171-179. The workshops have indeed been very successful and it was planned to increase these activities. Future workshops will include the following: Fontainebleau, France, June 9-l 3, 1992 Topic: “Combined treatment modalities in lung cancer” London, England, May 1993 Topic: “Workshop on Intra-Thoracic
Staging”
Bruges, Belgium, September 1993 Topic: “Fourth IASLC Workshop on Non-Small Cell Lung Cancer” Cape Town, South Africa, September S-10, 1993 Topic: “Improving the quality of life and supportive management in patients with lung cancer”
116 Zurich, Switzerland, September 1993 Topic: “3rd International workshop on lung tumor and differentiation
antigens”
Japan, 1993 Topic to be decided in the near future. Finland, 1993 Topic: “4th IASLC Workshop on Small Cell Lung Cancer” In addition, educational programs and courses will be encouraged with the first one taking place in: Prague, Czechoslovakia, Sept. 13-l 5, 1992, and another one together with the European School of Oncology in May 3-7, 1993. Because of the increasing activities, the Board of Directors decided to set up guidelines for the planning and execution of both world conferences and workshops.
Lung Cancer The journal has now been converted from a journal containing news for the members to be a journal accepting peer-reviewed papers and review articles, editorials, critical comments, etc. Fig. 2 indicates the number of papers submitted to the journal during the last 3 years and Fig. 3 the number of pages. The authorship represents a great number of countries, e.g. 17 countries in 1991, and is thus in fact global. The circulation is over 1200 with 4/5 consisting of members of the IASLC. The journal has thus reached a size that should fertilize further expansion of the journal. Replacement was going to take place on the Editorial Board in order to effectuate rotation every 3 years.
LUNG CANCER - No. of Papers
Fig. 2.
117
LUNG CANCER - No. of Pages 350, 300 250 I
50 0I
1985
1988
1986
1991
Fig. 3.
IASLC Merit Award 1991 Thanks to a donation it has been possible to create an IASLC Award. The merits of the prize winner should include the following: * An IASLC member for at least 10 years * A member who over the years has manifested himself/herself at an international as a person engaged in the field of lung cancer either preclinically or clinically
level
* A member who has promoted the activities of the IASLC The Nominating Committee consists of the Officers and the Members of the Board and it was decided that the first year the Merit Award should be given to Clifton F. Mountain, Houston, Texas, USA. Miscellaneous Heine H. Hansen informed that thanks to the success of the IASLC and the expansion that has taken place, increasing interest has been shown the activities of the organization from the pharmaceutical industry. Bristol-Myers Squibb have expressed their willingness to provide IASLC with large grants in 1991 and in the coming years. Similarly, Asta Werke will give support to the IASLC. Some of the grants will be used to create support to educational workshop, consensus reports, invitation of younger colleagues to the meetings,
118
and awards to young investigators. The oranization was very thankful for this support, which makes possible an expansion of the activities. Unanimous support by the IASLC was given to a draft on antismoking measures prepared by the EEC. Ad 2: Report from the ‘fkeasurer R. Joss gave an updated report concerning the financial status of the IASLC. The income has been limited, and it had not been possible nearly to cover all the expenses of running the office in Copenhagen and the Treasurer’s office in Switzerland. Accordingly, the budget does not give a true picture of all the expenses. The economy was mainly burdened by the fact that only 606 out of 922 have paid their membership dues in 1991. One additional memo will be forwarded to the non-paying members with a request for payment of the annual dues with subsequent annulation of the membership if no payment has been received within 2 months. The use of credit cards will be made available in the future. The membership fee for the next years was set to US$ 100.
Ad 3: Report from the Auditing Committee The Auditing Committee (Matson, Finland; Sculier, Belgium; Motta, Italy) informed that the Treasurer’s report had been reviewed and accepted. Ad 4: Election of New Board Members and Officers The president has received a written report from the Chairman of the Nominating Committee (R.L. Souhami) who on behalf of the Nominating Committee (P. Drings, Germany; D. Payne, Canada; C.F. Mountain, USA; Y. Shimosato, Japan) unanimously suggested that Paul A. Bunn be elected as the new president-elect, Ugo Pastorino, Italy as the new Secretary, while P. Rocmans and Y. Shimosato should be elected as new members of the Board. The suggestions were all approved unanimously by the assembly.
Ad 5: Miscellaneous D. Payne, Canada, inquired about the procedures of electing the officers and the Nominating Committee. Hansen gave a detailed summary of the procedures according to the Bylaws of the IASLC, article 7, section 2. The Bylaws are to be found in the membership roster. Bleehen thanked the past president for his long-term commitment to the IASLC and expressed the hope that he will continue his various activities for the organization.
113
LUNG 00110
Minutes: General Assembly International
Association
for the Study of Lung Cancer
Melbourne, November 14th, 1991 Agenda: 1. 2. 3. 4. 5.
Report from the President Report from the Treasurer Report from the Auditing Committee Election of new Officers and Board Members Miscellaneous
Ad 1: Report from the President Heine H. Hansen summarized the development of the various activities of the organization since the 5th World Conference on Lung Cancer in Interlaken, Switzerland, covering the following items: Membership
A further increase in membership was noted bringing the total number of members to 951 - see Fig. 1 and Table 1. The Middle East, Eastern Europe, Africa and South America are still poorly represented. A supplement to the membership roster will be distributed in 1992. World Conferences
6th World Conference, Melbourne, was very well attended, with roughly 1200 registrants, of whom more than 600 were non-members. A detailed report from the Secretary General, Dr. David Ball, will later be published in Lung Cancer. 7th World Conference is scheduled to take place in Colorado Springs, 1994, June 26July with Paul A. Bunn as the organizer.
1
8th World Conference is scheduled to take place in Europe 1997 and an announcement concerning the conditions will be placed in Lung Cancer with the deadline for applications to be submitted before September 1, 1993. 9th World Conference, year 2000 will take place in the Far East. An announcement will appear in Lung Cancer in 1993 with the decision to be taken no later than January 1, 1994.
114
I.A.S.L.C. Members 1974 - 1991
600
1991
1988 Fig. I.
TABLE 1 Members of the I.A.S.L.C. by country Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Colombia Czechoslovakia Denmark Egypt Finland France
I
24 I 11 6 1 32 1 24 2 2 24 2 2 21
Germany Greece Hong Kong Hungary India Indonesia Iran Ireland Israel Italy Japan Korea Latvia Lithuania Mexico
13 I 4 3 4
I 1 1 2 41 260 1
1 1 2
The Netherlands New Zealand Norway Panama Poland Portugal S. Africa Spain Sweden Switzerland Taiwan U.K. U.S.A. Venezuela Yugoslavia New Members 1991 Retired Members 1990-1991 Total
15
1 5
I 6 9 5 6 12 10 11 II 245 1 3 56 22 900
115 Workshops
During the last 3 years the following workshops have taken place: “Workshop on Combined Radiotherapy Modalities in Lung Cancer”, Le Havre, France,
June 1987. “Third Workshop on Small Cell Lung Cancer”, Elsinore, Denmark, June 1989. “Second Workshop on Therapy of Non-Small Cell Lung Cancer “, Bruges, Belgium, June
1990. “Third Lung Tumour Biology Workshop”, Cambridge, England, August 1990.
The following proceedings have been published in Lung Cancer 198881991: International Conference on Hormones, Growth Factors and Oncogenes in Pulmonary Carcinoma. Edited by: George D. Sorenson, 1988;4: 117-220. Fifth World Conference on Lung Cancer, Interlaken, Switzerland. Edited by: Rudolf A. Joss and Kurt W. Brunner, 1988;4:Suppl. Workshop on Combined Radiotherapy Modalities in Lung Cancer, Le Havre, France. Summary by: R. Arriagada and T. Le Chevalier, 1989;5:15-18. The Guangzhou First Symposium on Lung Cancer. Summary by: Du Yingxiu, 1989;5:37-40. Third Workshop on Small Cell Lung Cancer, Elsinore, Denmark. Edited by: Heine H. Hansen and Paul E.G. Kristjansen, 1989;5: 119-326. An International Conference on Lung Cancer, Boston, Massachusetts. Boston University Medical Center in cooperation with I.A.S.L.C. Summary by: S.D. Bernal and P.J. Hesketh, 1990;5-6:192-208. Second Workshop on Therapy of Non-Small Cell Lung Cancer, Bruges, Belgium. Edited by: P. van Houtte, 1991;7:1-132. Third Lung Tumour Biology Workshop, Cambridge, England. Report by: N.M. Bleehen, PH. Rabbits and J.G. Reeve, 1991;7:171-179. The workshops have indeed been very successful and it was planned to increase these activities. Future workshops will include the following: Fontainebleau, France, June 9-l 3, 1992 Topic: “Combined treatment modalities in lung cancer” London, England, May 1993 Topic: “Workshop on Intra-Thoracic
Staging”
Bruges, Belgium, September 1993 Topic: “Fourth IASLC Workshop on Non-Small Cell Lung Cancer” Cape Town, South Africa, September S-10, 1993 Topic: “Improving the quality of life and supportive management in patients with lung cancer”
116 Zurich, Switzerland, September 1993 Topic: “3rd International workshop on lung tumor and differentiation
antigens”
Japan, 1993 Topic to be decided in the near future. Finland, 1993 Topic: “4th IASLC Workshop on Small Cell Lung Cancer” In addition, educational programs and courses will be encouraged with the first one taking place in: Prague, Czechoslovakia, Sept. 13-l 5, 1992, and another one together with the European School of Oncology in May 3-7, 1993. Because of the increasing activities, the Board of Directors decided to set up guidelines for the planning and execution of both world conferences and workshops.
Lung Cancer The journal has now been converted from a journal containing news for the members to be a journal accepting peer-reviewed papers and review articles, editorials, critical comments, etc. Fig. 2 indicates the number of papers submitted to the journal during the last 3 years and Fig. 3 the number of pages. The authorship represents a great number of countries, e.g. 17 countries in 1991, and is thus in fact global. The circulation is over 1200 with 4/5 consisting of members of the IASLC. The journal has thus reached a size that should fertilize further expansion of the journal. Replacement was going to take place on the Editorial Board in order to effectuate rotation every 3 years.
LUNG CANCER - No. of Papers
Fig. 2.
117
LUNG CANCER - No. of Pages 350, 300 250 I
50 0I
1985
1988
1986
1991
Fig. 3.
IASLC Merit Award 1991 Thanks to a donation it has been possible to create an IASLC Award. The merits of the prize winner should include the following: * An IASLC member for at least 10 years * A member who over the years has manifested himself/herself at an international as a person engaged in the field of lung cancer either preclinically or clinically
level
* A member who has promoted the activities of the IASLC The Nominating Committee consists of the Officers and the Members of the Board and it was decided that the first year the Merit Award should be given to Clifton F. Mountain, Houston, Texas, USA. Miscellaneous Heine H. Hansen informed that thanks to the success of the IASLC and the expansion that has taken place, increasing interest has been shown the activities of the organization from the pharmaceutical industry. Bristol-Myers Squibb have expressed their willingness to provide IASLC with large grants in 1991 and in the coming years. Similarly, Asta Werke will give support to the IASLC. Some of the grants will be used to create support to educational workshop, consensus reports, invitation of younger colleagues to the meetings,
118
and awards to young investigators. The oranization was very thankful for this support, which makes possible an expansion of the activities. Unanimous support by the IASLC was given to a draft on antismoking measures prepared by the EEC. Ad 2: Report from the ‘fkeasurer R. Joss gave an updated report concerning the financial status of the IASLC. The income has been limited, and it had not been possible nearly to cover all the expenses of running the office in Copenhagen and the Treasurer’s office in Switzerland. Accordingly, the budget does not give a true picture of all the expenses. The economy was mainly burdened by the fact that only 606 out of 922 have paid their membership dues in 1991. One additional memo will be forwarded to the non-paying members with a request for payment of the annual dues with subsequent annulation of the membership if no payment has been received within 2 months. The use of credit cards will be made available in the future. The membership fee for the next years was set to US$ 100.
Ad 3: Report from the Auditing Committee The Auditing Committee (Matson, Finland; Sculier, Belgium; Motta, Italy) informed that the Treasurer’s report had been reviewed and accepted. Ad 4: Election of New Board Members and Officers The president has received a written report from the Chairman of the Nominating Committee (R.L. Souhami) who on behalf of the Nominating Committee (P. Drings, Germany; D. Payne, Canada; C.F. Mountain, USA; Y. Shimosato, Japan) unanimously suggested that Paul A. Bunn be elected as the new president-elect, Ugo Pastorino, Italy as the new Secretary, while P. Rocmans and Y. Shimosato should be elected as new members of the Board. The suggestions were all approved unanimously by the assembly.
Ad 5: Miscellaneous D. Payne, Canada, inquired about the procedures of electing the officers and the Nominating Committee. Hansen gave a detailed summary of the procedures according to the Bylaws of the IASLC, article 7, section 2. The Bylaws are to be found in the membership roster. Bleehen thanked the past president for his long-term commitment to the IASLC and expressed the hope that he will continue his various activities for the organization.